Telomeres Might Predict Lung Cancer Recurrence
Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.
A bit of summer trivia: After George H. Whipple won the 1934 Noble Prize for his discoveries regarding anemia, what happened to his original, handwritten notes?
7/17/2014 | 0 comments
UR scientist Lisa Beck, M.D., led a clinical investigation for a new drug to treat eczema or atopic dermatitis, with encouraging results that were reported in the New England Journal of Medicine.
7/10/2014 | 0 comments
Antibiotics given to preterm newborns disrupt the diversity of gut bacteria, but a shorter, two-day course of drugs has less impact than seven days or more of antibiotics, according to a study from a team in Pediatrics at UR Medicine’s Golisano Children’s Hospital.
7/2/2014 | 1 comment
The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue their study of a gene network that controls cancer progression, with a focus on pancreatic cancer.
6/25/2014 | 0 comments
The University of Rochester has provided a sneak peek of one of its newest – and perhaps coolest – research resources, one that will help scientists better understand and manipulate large and complex sets of data.
6/24/2014 | 0 comments